CASP3 and breast carcinoma: These findings provide a novel epigenetic regulating mechanism of JMJD2C by caspase-3 cleavage, and the single nucleotide polymorphism rs2296067 of JMJD2C alters the cleavage by caspase-3 and affect the prognosis of breast cancer.